OZABIO proudly participated in Vitafoods Asia 2025, one of the region’s most influential platforms for nutraceuticals and functional ingredients. The event brought together industry leaders, innovators, and forward-thinking brands, creating a dynamic space to explore the future of health and nutrition.
At the exhibition, OZABIO showcased its advanced LIPOZA liposomal technology, highlighting how next-generation delivery systems are transforming ingredient performance through enhanced bioavailability, stability, and targeted nutrient delivery. Our presence reflected our commitment to driving science-backed innovation and delivering solutions that go beyond conventional formulations.
Participating in Vitafoods Asia 2025 provided OZABIO with a valuable opportunity to:
● Connect with global partners, manufacturers, and nutraceutical brands
● Present our cutting-edge liposomal solutions to a wider audience
● Engage in meaningful discussions around emerging trends, regulatory developments, and market demands
The event reinforced OZABIO’s position as a trusted innovation partner, focused on enabling brands to create high-performance, differentiated products.
Our participation at Vitafoods Asia reflects OZABIO’s ongoing mission to advance nutraceutical science and strengthen global collaborations. Events like these allow us to stay at the forefront of industry evolution while continuously refining our technologies to meet the changing needs of the market.
Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603
Mail: [email protected]
Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA
© 2026 OzaBio | All Rights Reserved.
Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin
Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.
For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.
Fill out the form below and we'll get back to you soon
* indicates required question